Commonwealth Equity Services, LLC Evolus, Inc. Transaction History

Commonwealth Equity Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$7.6 - $10.53 $760 - $1,053	-100 Reduced 0.93%	10,700 $113,000
Q2 2023 Aug 10, 2023	SELL	$7.23 - $10.52 $21 - $31	-3 Reduced 0.03%	10,800 $79,000
Q1 2023 May 11, 2023	BUY	$7.81 - $11.05 $23 - $33	3 Added 0.03%	10,803 $91,000
Q2 2022 Jul 19, 2022	SELL	$10.22 - $13.94 $2,044 - $2,788	-200 Reduced 1.82%	10,800 $125,000
Q4 2021 Jan 31, 2022	SELL	$5.37 - $8.38 $537 - $838	-100 Reduced 0.9%	11,000 $71,000
Q2 2021 Aug 11, 2021	SELL	$8.42 - $13.96 $8,420 - $13,960	-1,000 Reduced 8.26%	11,100 $140,000
Q1 2021 May 04, 2021	BUY	$3.2 - $16.51 $38,720 - $199,771	12,100 New	12,100 $157,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.